Board of Directors

The Novartis Board of Directors is responsible for the direction, strategy, organization and administration of the company. The Board comprises 13 members with Joerg Reinhardt as chairman.

Download the Board of Director Committee Organizational Chart (PDF 0.1 MB)

Blue icon of a business woman
Chairman
Joerg Reinhardt, Ph.D.
the oncoprotein c-Myc
Vice Chairman | Lead Independent Director
Enrico Vanni, Ph.D.
Fruit fly sitting on an apple
Board member since 2015
Nancy C. Andrews, M.D., Ph.D.
Chemists Joseph Schoepfer and Xavier Pellé
Board member since 2016
Ton Buechner
RNA strand
Board member since February 28, 2019
Patrice Bula
White petunias.
Board member since 2016
Elizabeth (Liz) Doherty
Ann Fudge, Member of the Board of Directors
Board member since 2008
Ann Fudge
Veli-Pekka Jaakola, Center for Proteomic Chemistry
Board member since February 28, 2020
Bridgette Heller
Protein production in action in a cell.
Board member since 2017
Frans van Houten
Wilhelm Weihofen, Center for Proteomic Chemistry
Board member since February 28, 2020
Simon Moroney, D.Phil.
Live Magazine
Board member since 2006
Andreas von Planta, Ph.D.
Charles L. Sawyers, M.D., Member of the Board of Directors
Board member since 2013
Charles L. Sawyers, M.D.
Black lives matter
Board member since 2013
William T. Winters
A group of people in a business meeting
Corporate Secretary
Charlotte Pamer-Wieser, Ph.D.

Source URL: https://www.novartis.com/about/board-directors

List of links present in page